77415-55-5 Usage
Uses
Used in Organic Synthesis:
2,7-Diaza-spiro[4.4]nonane 2HBr is used as a building block for the synthesis of various organic compounds due to its reactive bromide group and heterocyclic structure, which facilitate a range of chemical reactions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 2,7-Diaza-spiro[4.4]nonane 2HBr is utilized as a key intermediate in the development of pharmaceuticals. Its unique structure allows for the creation of novel drug candidates with potential therapeutic applications.
Used in Drug Discovery:
2,7-Diaza-spiro[4.4]nonane 2HBr plays a role in drug discovery processes, where it may be employed to identify new lead compounds or optimize existing ones. Its reactivity and structural features make it a promising candidate for the design of bioactive molecules.
Used in Material Science:
2,7-Diaza-spiro[4.4]nonane 2HBr is also used in the development of new materials, where its chemical properties can contribute to the creation of advanced materials with specific properties for various applications.
Used in Chemical Research:
In academic and industrial research settings, 2,7-Diaza-spiro[4.4]nonane 2HBr serves as a subject of study for understanding reaction mechanisms, exploring new synthetic routes, and discovering unexpected chemical behaviors.
Check Digit Verification of cas no
The CAS Registry Mumber 77415-55-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,4,1 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 77415-55:
(7*7)+(6*7)+(5*4)+(4*1)+(3*5)+(2*5)+(1*5)=145
145 % 10 = 5
So 77415-55-5 is a valid CAS Registry Number.
77415-55-5Relevant academic research and scientific papers
Rifamycin derivatives
-
Page/Page column 26, (2008/06/13)
Novel rifamycin derivatives of formula I (both hydroquinone and corresponding quinone (C1-C4) forms): or their salts, hydrates or prodrugs thereof, wherein: a preferred R comprises hydrogen, acetyl; L is a linker, a preferred linker group elements selected from any combination of 1 to 5 groups shown FIG. 1, provided L is not wherein R1 is H, methyl or alkyl. The inventive compounds exhibit valuable antibiotic properties. Formulations having these compounds can be used in the control or prevention of infectious diseases in mammals, both humans and non-humans. In particular, the compounds exhibit a pronounced antibacterial activity, even against multiresistant strains of microbes.
![2,7-diazaspiro[4.4]nonane](/Databaselist/images/loading.webp)
